Kazia Therapeutics annual debt-to-assets ratio
2017
2018
2022
2023
2024
2025
Kazia Therapeutics Debt-to-Assets Ratio Growth & History (KZIA)
Kazia Therapeutics's debt-to-assets ratio was 0.07 for fiscal 2025.
View full Kazia Therapeutics company overviewKazia Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 0.07 | 0.04 | +122.29% |
| 2024 | 2024-06-30 | 0.03 | −0.03 | −54.07% |
| 2023 | 2023-06-30 | 0.06 | 0.01 | +24.67% |
| 2022 | 2022-06-30 | 0.05 | — | — |
| 2018 | 2018-06-30 | 0.00 | 0.00 | +970.61% |
| 2017 | 2017-06-30 | 0.00 | — | — |
Kazia Therapeutics quarterly debt-to-assets ratio
Q4.17
Q4.18
Q4.22
Q2.23
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | 0.00 | −0.01 | −82.32% |
| Q4 2025 | 2025-06-30 | 0.07 | 0.04 | +122.29% |
| Q2 2025 | 2024-12-31 | 0.01 | −0.01 | −46.68% |
| Q4 2024 | 2024-06-30 | 0.03 | −0.03 | −54.07% |
| Q2 2024 | 2023-12-31 | 0.01 | −0.01 | −25.74% |
| Q4 2023 | 2023-06-30 | 0.06 | 0.01 | +24.67% |
| Q2 2023 | 2022-12-31 | 0.02 | — | — |
| Q4 2022 | 2022-06-30 | 0.05 | — | — |
| Q4 2018 | 2018-06-30 | 0.00 | 0.00 | +970.61% |
| Q4 2017 | 2017-06-30 | 0.00 | — | — |
Kazia Therapeutics debt-to-assets ratio trends
Between the periods ended 2017-06-30 and 2025-06-30, Kazia Therapeutics's debt-to-assets ratio increased from 0.00 to 0.07, a change of 0.07. The latest reported quarter, Q2 2026, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Kazia Therapeutics source filings ↗